Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
18,847 total articles
Americold Realty Trust, Inc., a global leader in temperature-controlled logistics and real estate, announced it will release its first quarter 2026 financial results before market open on May 7, 2026, followed by a conference call at 8 a.m. Eastern Time. The company operates over 230 refrigerated facilities worldwide and serves as a key component o…
Kymera Therapeutics announced that its investigational drug KT-621 received Fast Track designation from the U.S. FDA for the treatment of moderate to severe eosinophilic asthma. KT-621, an oral STAT6 degrader, is currently in Phase 2b clinical trials for asthma and atopic dermatitis, with data expected in 2027. The designation may expedite developm…
Aeluma, a Nasdaq-listed semiconductor company, announced new contracts exceeding $4 million from the U.S. government to advance its heterogeneous integration platform focused on quantum dot lasers and quantum nonlinear materials. These contracts support Aeluma's commercialization strategy and strengthen partnerships with manufacturing leaders Tower…
Seer, Inc., a Nasdaq-listed proteomics company, announced receipt of a non-binding, unsolicited proposal from the Radoff-JEC Group to acquire all outstanding Class A shares for $2.25 per share plus a contingent value right. The group also nominated three director candidates for the upcoming 2026 Annual Meeting. The Seer Board will review the propos…
ImageneBio announced a $30 million private placement led by Coastlands Capital to fund further development of its lead immuno-modulatory candidate IMG-007 in alopecia areata and atopic dermatitis. The proceeds will support ongoing Phase 2b trials and late-stage development activities, highlighting investor confidence in IMG-007's differentiated mec…
Ocular Therapeutix announced positive additional 52-week data from its SOL-1 Phase 3 trial of AXPAXLI, showcasing unmatched durability and sustained disease control in treating wet age-related macular degeneration. The data reinforce AXPAXLI's superiority over aflibercept with significantly prolonged efficacy and favorable safety, underpinning the …
CBAK Energy Technology, Inc. reported strong 2025 performance in Chinese cylindrical battery shipments, securing 2nd place in the 26700/26650 segment and 3rd in the 32140 segment. The company shipped over 47 million cylindrical batteries, benefiting from its proprietary full-tab technology. It is targeting growth in Automated Guided Vehicle robotic…
Spyre Therapeutics announced positive topline 12-week induction data from Part A of the Phase 2 SKYLINE trial for SPY001, an extended half-life anti-α4β7 antibody, showing statistically significant improvement in histopathology and clinical remission in moderate-to-severe ulcerative colitis. The trial met its primary endpoint with a significant red…
NRx Pharmaceuticals has appointed Glenn Tyson as its first Chief Commercial Officer to lead commercialization efforts as the company anticipates approval of its preservative-free ketamine product and prepares for a new drug application submission to expand ketamine use for depression and suicidality. Tyson brings 25 years of industry experience, in…
Eldorado Gold Corporation will release its financial and operational results for the first quarter of 2026 on April 30, 2026, and will host a conference call on May 1, 2026. The company operates gold and base metals mining and exploration projects in Canada, Türkiye, and Greece, and its shares trade on both the TSX and NYSE American exchanges.
Perella Weinberg Partners announced the definitive agreement to acquire Gleacher Shacklock, a leading independent UK advisory firm, in a move to strengthen its footprint in the UK's largest advisory market and enhance cross-border transaction capabilities between the UK, Europe, and North America. The transaction is expected to close in the second …
Caliber (Nasdaq: CWD), a US-based diversified real estate and digital asset management platform, announced that PURE Pickleball & Padel's 196,000-square-foot indoor sports facility in Scottsdale, Arizona, has received all required building permits. This milestone paves the way for groundbreaking, expected after construction financing closes. The fa…
Old National Bancorp announced a strategic realignment of its commercial banking leadership, including the hiring of Chris Doyle as President of Commercial Banking and the promotion of John C. Thurston to President of Corporate Banking. Additional leadership adjustments were made in Treasury Management and service delivery to enhance client service…
Calavo Growers, Inc., a leader in fresh produce sourcing and processing, declared a quarterly cash dividend of $0.20 per share. The company amended the dividend record date to April 24, 2026, while maintaining the payment date of April 29, 2026. This adjustment complies with Nasdaq's notice requirements without changing dividend value or payment ti…
Allogene Therapeutics announced encouraging interim futility analysis results from its Phase 2 ALPHA3 trial evaluating cemacabtagene ansegedleucel (cema-cel), an allogeneic CAR T therapy, in first-line consolidation for large B-cell lymphoma (LBCL). The cema-cel arm showed a 58.3% minimal residual disease (MRD) clearance rate versus 16.7% in the ob…
BullFrog AI Holdings announced a significant commercial feasibility agreement with a top 5 global pharmaceutical company to use its AI platform bfLEAP® to identify novel drug targets in major depressive disorder. The company also strengthened its balance sheet with recent financings to support operations into late 2027 and is advancing multiple dis…
ASP Isotopes Inc. presents a comprehensive business update highlighting operational milestones across its nuclear medicine, electronics, and nuclear energy platforms. The company anticipates first commercial shipments of several enriched isotopes including Silicon-28, Carbon-14, and Ytterbium-176 in 2026, expects to reach helium production capacity…
Palvella Therapeutics, a clinical-stage biopharmaceutical company specializing in rare skin diseases and vascular malformations, announced the appointment of John D. Doux, M.D., M.B.A., a recognized dermatologist and investor in rare skin disease therapies, to its Board of Directors. Dr. Doux's deep medical experience and previous advocacy for inno…
PMGC Holdings Inc.'s subsidiary NorthStrive Biosciences announces the successful transfer of the EL-32 Working Cell Bank to a U.S.-based fermentation facility, initiating manufacturing optimization aimed at scalable and cost-effective production. EL-32 is an engineered probiotic therapeutic targeting muscle preservation by modulating myostatin and …
Hillman Solutions Corp. announced the acquisition of Delaney Hardware, a U.S.-based door hardware supplier serving residential, multifamily, and commercial construction markets. This acquisition strategically expands Hillman's pro distribution categories by adding door hardware products and broadens its builder's hardware inventory. The company exp…
3D Systems has unveiled its next-generation SLA 825 Dual stereolithography system offering 22% larger build volume and up to 25% faster print speeds to enhance production throughput. Alongside, it launched AddiTrak™, an advanced on-premises factory software platform for real-time fleet monitoring and process control. These innovations aim to accele…
Oil-Dri Corporation of America (NYSE: ODC) was named a 2026 USA TODAY Top Workplaces winner, an accolade based on confidential employee feedback showcasing the company's commitment to a collaborative and supportive work environment. This recognition highlights Oil-Dri's people-first culture, emphasizing transparency, employee engagement, and opport…
Akebia Therapeutics has dosed the first participants in a Phase 1 clinical trial of AKB-9090, an internally developed HIF-PH inhibitor aimed at treating cardiac surgery-associated acute kidney injury (AKI). The randomized, double-blind, placebo-controlled study will assess safety, tolerability, pharmacokinetics, and pharmacodynamics in healthy adul…
Revolution Medicines announced positive topline results from the RASolute 302 Phase 3 clinical trial evaluating daraxonrasib, an oral targeted therapy, in previously treated metastatic pancreatic ductal adenocarcinoma patients. The trial met all primary and key secondary endpoints, showing a significant improvement in progression-free survival and …
CVRx, Inc. announced preliminary unaudited financial results for Q1 2026, reporting approximately 20% revenue growth year over year to $14.7-$14.8 million. The company noted improvements in Medicare Advantage prior authorization approval rates following implementation of Category I CPT codes, and activated the first site in the BENEFIT-HF clinical …
